TY  - GEN
AU  - Clark,Peter E
TI  - The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy
SN  - 1523-1755
PY  - 2009///1224
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Aryl Hydrocarbon Receptor Nuclear Translocator
KW  - genetics
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Drug Design
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Hypoxia-Inducible Factor 1, alpha Subunit
KW  - Kidney Neoplasms
KW  - Protein Kinase Inhibitors
KW  - Protein Kinases
KW  - drug effects
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - antagonists & inhibitors
KW  - Signal Transduction
KW  - TOR Serine-Threonine Kinases
KW  - Translational Research, Biomedical
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - Von Hippel-Lindau Tumor Suppressor Protein
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
UR  - https://doi.org/10.1038/ki.2009.296
ER  -